Evidence map›Paper›PMID 33311593›Full record

ArticleBone marrow transplantation2021

Risk factors and outcomes of follicular lymphoma after allogeneic hematopoietic stem cell transplantation using HLA-matched sibling, unrelated, and haploidentical-related donors.

Juan Montoro, Pedro Chorão, Leyre Bento, Mónica Cabrero, Carmen Martín, Silvana Novelli, Irene García Cadenas, Gonzalo Gutiérrez, Oriana López-Godino, Christelle Ferrá and 16 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Juan Montoro *Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain. juanmontorogomez@gmail.com.ORCID http://orcid.org/0000-0003-0024-8068
Pedro Chorão *Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.ORCID http://orcid.org/0000-0001-6741-971X
Leyre BentoDepartment of Hematology, Hospital Universitario Son Espases, Mallorca, Spain.
Mónica CabreroDepartment of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain.ORCID http://orcid.org/0000-0001-7586-4792
Carmen MartínDepartment of Hematology, Hospital Universitario Reina Sofía, Córdoba, Spain.
Silvana NovelliDepartment of Hematology, Hospital de la Santa Creu i San Pau, Barcelona, Spain.ORCID http://orcid.org/0000-0001-8750-0195
Irene García CadenasDepartment of Hematology, Hospital de la Santa Creu i San Pau, Barcelona, Spain.ORCID http://orcid.org/0000-0002-2994-9055
Gonzalo GutiérrezBone Marrow Transplant Unit, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Spain.ORCID http://orcid.org/0000-0003-4084-8279
Oriana López-GodinoDepartment of Hematology, Hospital General Universitario Morales Meseguer, Murcia, Spain.
Christelle FerráDepartment of Hematology, Hospital Germans Trials i Pujol, Barcelona, Spain.ORCID http://orcid.org/0000-0003-4571-5125
Mariana Bastos-OreiroDepartment of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.ORCID http://orcid.org/0000-0002-9431-4646
Ariadna PérezDepartment of Hematology, Hospital Clínico, Valencia, Spain.
Rocío ParodyDepartment of Hematology, Institut Català d'Oncologia (ICO) - Hospital Duran i Reynals, Barcelona, Spain.
José A Pérez SimónDepartment of Hematology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina (IBIS/CIBERONC), Universidad de Sevilla, Sevilla, Spain.
Lucrecia YañezDepartment of Hematology, Hospital Universitario Marqués de Valdecilla-IDIVAL, Santander, Spain.
Andrés SánchezDepartment of Hematology, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
Joud ZanabiliDepartment of Hematology, Hospital Universitario Central de Asturias, Oviedo, Spain.ORCID http://orcid.org/0000-0001-7783-4642
Ma Rosario VarelaDepartment of Hematology, Complejo Hospitalario A Coruña, La Coruña, Spain.
Raúl CórdobaDepartment of Hematology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
Teresa ZudaireDepartment of Hematology, Complejo Hospitalario de Navarra, Pamplona, Spain.
Ana Jiménez-UbietoDepartment of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Jaime SanzDepartment of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Ana SuredaDepartment of Hematology, Institut Català d'Oncologia (ICO) - Hospital Duran i Reynals, Barcelona, Spain.
Dolores CaballeroDepartment of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain.
José Luis PiñanaDepartment of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.ORCID http://orcid.org/0000-0001-8533-2562
GETH and GELTAMO Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationLymphoma, FollicularHumansRisk FactorsSiblingsTissue DonorsTransplantation, HomologousUnrelated Donors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.